This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Category: 6. Health
-
Just a moment…
Just a moment… -

Assessing High-Dose Versus Standard-Dose Influenza Vaccine Protection Against Severe Disease Outcomes
This infographic summarizes findings from FLUNITY-HD, the largest ever individually randomized influenza vaccine effectiveness trial. Conducted across nearly half a million older adults, the study provides valuable real-world insights into the…
Continue Reading
-
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading
-

Psychiatric Comorbidities, Quality-of-Life Burdens Associated with Pediatric Vitiligo
Pediatric vitiligo is linked with increased symptom burden, psychiatric comorbidity prevalence, and mild-to-moderate quality of life (QoL) impairment, new findings suggest, indicating the necessity of psychosocial evaluation integration.1These…
Continue Reading
-
Congo’s last Ebola patient has been discharged, raising hopes that outbreak might be over – The Washington Post
- Congo’s last Ebola patient has been discharged, raising hopes that outbreak might be over The Washington Post
- Last Ebola patient discharged in DR Congo, WHO says Al Jazeera
- WHO says DRC could declare end of Ebola outbreak by December Xinhua
Continue Reading
-

Sex-related disparities in migraine recognition and management: insights from a tertiary headache center cohort | The Journal of Headache and Pain
Patient selection & characteristics
Between December 2015 and January 2023, a total of 3,264 patients attended their first consultation at our tertiary headache center and were given out comprehensive history questionnaires. Of 1,780 returned, 364…
Continue Reading
-

EV-202: EV/Pembro Combo Shows 39% ORR in First-Line PD-L1+ HNSCC | Targeted Oncology
Enfortumab vedotin-ejfv (Padcev) in combination with pembrolizumab (Keytruda) yielded meaningful clinical activity as first-line treatment for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) with a PD-L1…
Continue Reading
-

Largest-ever £26 million trial launches across UK to slow Parkinson’s disease
Image: ©Naeblys | iStock The world’s largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt disease progression
The world’s largest clinical trial…
Continue Reading
-

Childhood food allergies significantly reduced in US since early peanut exposure guidelines
A major US study shows childhood food allergies have significantly declined since early peanut exposure guidelines were adopted in the past decade.

Childhood food allergies in the United States have significantly declined in the…
Continue Reading
-

Scientists discover method to reactivate immune system against bowel cancer
Researchers at the University of Galway in Ireland have made a significant breakthrough in understanding how bowel cancer evades the body’s natural defenses, discovering a method to reactivate the immune system against the disease. The study…
Continue Reading